Table 3. Standardized Mortality Ratio (SMR) of malignant disease (Reference: Korean men).
Non-production | Production | Total | ||
Person-years | 38,017 | 154,584 | 192,600 | |
All malignant diseases | N | 41 | 274 | 315 |
SMR | 0.64 | 1.04 | 0.96 | |
95%CI | 0.46–0.87 | 0.92–1.17 | 0.86–1.07 | |
Stomach | N | 4 | 53 | 57 |
SMR | 0.33 | 1.08 | 0.93 | |
95%CI | 0.09–0.84 | 0.81–1.41 | 0.70–1.20 | |
Colon | N | 5 | 18 | 23 |
SMR | 1.21 | 1.06 | 1.09 | |
95%CI | 0.39–2.83 | 0.63–1.68 | 0.69–1.64 | |
Liver | N | 14 | 73 | 87 |
SMR | 0.86 | 0.99 | 0.97 | |
95%CI | 0.47–1.44 | 0.78–1.25 | 0.78–1.20 | |
Pancreas | N | 2 | 9 | 11 |
SMR | 0.74 | 0.78 | 0.78 | |
95%CI | 0.08–2.66 | 0.36–1.49 | 0.39–1.39 | |
Lung | n | 9 | 56 | 65 |
SMR | 0.67 | 1.06 | 0.98 | |
95%CI | 0.31–1.27 | 0.80–1.38 | 0.76–1.25 | |
Urinary bladder | N | 2 | 5 | 7 |
SMR | 2.91 | 2.04 | 2.23 | |
95%CI | 0.33–10.51 | 0.66–4.77 | 0.90–4.60 | |
Lympohematopoietic | N | 2 | 16 | 18 |
SMR | 0.75 | 1.44 | 1.3 | |
95%CI | 0.08–2.70 | 0.82–2.33 | 0.77–2.06 |